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Abstract
Human and animal African trypanosomiasis (HAT & AAT, respectively) remain a significant
health and economic issue across much of sub-Saharan Africa. Effective control of AAT and
potential eradication of HAT requires affordable, sensitive and specific diagnostic tests that
can be used in the field. Small RNAs in the blood or serum are attractive disease biomarkers
due to their stability, accessibility and available technologies for detection. Using RNAseq,
we have identified a trypanosome specific small RNA to be present at high levels in the
serum of infected cattle. The small RNA is derived from the non-coding 7SL RNA of the pep-
tide signal recognition particle and is detected in the serum of infected cattle at significantly
higher levels than in the parasite, suggesting active processing and secretion. We show
effective detection of the small RNA in the serum of infected cattle using a custom RT-qPCR
assay. Strikingly, the RNA can be detected before microscopy detection of parasitaemia in
the blood, and it can also be detected during remission periods of infection when no parasi-
taemia is detectable by microscopy. However, RNA levels drop following treatment with try-
panocides, demonstrating accurate prediction of active infection. While the small RNA
sequence is conserved between different species of trypanosome, nucleotide differences
within the sequence allow generation of highly specific assays that can distinguish between
infections with Trypanosoma brucei, Trypanosoma congolense and Trypanosoma vivax.
Finally, we demonstrate effective detection of the small RNA directly from serum, without
the need for pre-processing, with a single step RT-qPCR assay. Our findings identify a spe-
cies-specific trypanosome small RNA that can be detected at high levels in the serum of cat-
tle with active parasite infections. This provides the basis for the development of a cheap,
non-invasive and highly effective diagnostic test for trypanosomiasis.
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Author summary
African trypanosomes cause significant disease in humans and animals across sub-Saha-
ran Africa. For both human and animal infections diagnostics that can accurately identify
an active infection are lacking–this is particularly the case in animal disease where most
diagnosis is based upon clinical signs, which is not a specific or sensitive means of detect-
ing infection. There is therefore a significant unmet need for a pathogen marker of active
infection that accurately indicates whether an animal or human is currently infected.
Through analysing the blood of cattle infected with trypanosomes, we identified a short
sequence of RNA that was present at very high levels. This small RNA derives from the
trypanosome genome, and we could identify its presence in the genome of all three species
that are responsible for human and animal disease. We were able to design species-specific
tests, and showed that in samples from infected animals the assays were more sensitive
than the traditional microscope-based detection, importantly the signal disappeared rela-
tively quickly after successful treatment, and when treatment failed, the assay was able to
accurately identify when infection persisted. We also demonstrated that the causative
agent of human trypanosomiasis secretes the marker at similar levels to that seen in the
animal-infective trypanosomes. Therefore, we have discovered a marker of trypanosome
infection that is present at high levels in the blood of infected animals, disappears quickly
upon successful treatment, but is effective at detecting instances of unsuccessful treatment
and persistent infection. This represents a potentially powerful diagnostic tool for human
and animal trypanosomiasis.
Introduction
African trypanosomes, vector borne protozoa transmitted by tsetse flies (Glossina species),
cause Human African Trypanosomiasis (HAT) and Animal African Trypanosomiasis (AAT)
across sub-Saharan Africa. AAT, caused by Trypanosoma congolense, Trypanosoma vivax and
Trypanosoma brucei, infects approximately 70 million and kills 3 million cattle per year, and is
one of the most significant infectious disease constraints upon agriculture in the region [1].
HAT is caused by two variants of T. brucei, T. b. gambiense and T. b. rhodesiense, and in recent
years the impact of this disease has been significantly reduced through active case detection,
with<3,000 cases reported in 2015, down from ~50,000 in 2000 [2, 3]. However, new and
improved tools are required for both diseases; for AAT as a tool to begin to reduce the current
significant infection burden, and for HAT to facilitate the delivery of the WHO aim of HAT
elimination by 2030 [4, 5].
The ability to diagnose active infections is currently still a significant challenge for both
AAT and HAT. While there have been substantial efforts to develop new effective diagnostics
for HAT, currently the gold standards remain microscopy (with methods that concentrate–
e.g. microhaematocrit centrifugation, quantitative buffy coat or mini anion exchange centri-
fuge technique (mAECT) [6–9]–all providing increased sensitivity) and the card agglutination
test (CATT)–an antibody agglutination test based upon several VSGs expressed by T. b. gam-
biense [10] (for the latter assay there has also been recent adaptation to a rapid diagnostic test
platform [11, 12]). While some molecular tests (e.g. loop mediated isothermal amplification–
LAMP) have demonstrated promise [13], and for LAMP this has included the development of
field-applicable kits, these have not been widely utilised in the field [14]. Tests based on anti-
body and DNA have their well-recognised limitations (differentiating between exposure and
infection for the former and the potential for DNA persistence following treatment, as well as
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contamination, for the latter), and a test that enabled sensitive and specific detection of active
infection would be a significant advance. For AAT, diagnosis is still largely symptomatic with
inherent non-specificity given lack of pathognomonic clinical signs, and occasionally micros-
copy may be employed [15]. Investment in development of diagnostics for AAT is increasing,
with recent efforts defining antibody-based capture techniques for antigens that have been
described as conserved and highly expressed [16–18]. Indeed, this approach has resulted in the
first commercial diagnostic being brought to market in 2017 (VerY Diag, CEVA). Therefore,
available methods for both HAT and AAT have their limitations–the requirement for a test
that enables detection of active infection remains–both for potential utility in the field and
to improve, for example, accurate assessment of clinical efficacy of drugs and vaccines
(increasing areas of interest for AAT). An ideal marker for active infection is a pathogen-
derived molecule that is present in high enough levels in infected animals/patients to enable
sensitive detection, has properties that enable assignment to pathogen and species to a high
level of confidence, and, additionally, reduces in levels quickly following removal of the patho-
gen (e.g. by chemotherapy).
Small RNAs have received much interest as potentially useful diagnostic biomarkers, partic-
ularly in human medicine and cancers [19]. This is due to higher expression of particular
small RNAs (e.g. microRNAs [miRNAs]) in cancer cells. In these cases, diagnosis requires con-
firmation of higher levels of the small RNA species in comparison to non-affected cells/tissues.
For application to pathogens in contrast, the test would aim to identify the binary presence or
absence of a pathogen marker, a much simpler threshold to define. Trypanosomes produce
multiple small RNAs (although do not produce miRNAs) and in the best-characterised species,
T. brucei, there has been description of the small RNAome [20]. The T. brucei genome includes
identification of small RNA encoding loci, including rRNA, snoRNA, tRNA and siRNA [21,
22] (albeit only a proportion of these have been functionally validated). In addition, several
reports have outlined the RNA species secreted/excreted in the form of vesicles by related try-
panosomatids such as Trypanosoma cruzi and Leishmania major [23, 24]. There is less infor-
mation for T. congolense and T. vivax, although both species have annotated genomes available
with predicted small RNA-encoding genes [21, 25].
In the current study we describe a trypanosome small RNA species that is present in the
serum of infected animals at high levels. This small RNA is a 26-nucleotide segment of the 7SL
long non-coding RNA (‘7SL RNA’); the latter is usually described as a cytoplasmic non-coding
RNA that is part of the signal recognition particle (SRP) involved in protein translocation
across cell membranes. The 7SL-derived small RNA (hereafter termed ‘7SL-sRNA’) sequences
are species-specific, enabling the design of tests that differentiate between T. congolense, T.
vivax and T. brucei. The 7SL-sRNA is present at high levels in infected animals (equivalent to
levels of highly expressed bovine miRNAs), enabling robust detection both before detection by
microscopy and during periods of infection with subpatent parasitaemia. Importantly, follow-
ing post-curative treatment the levels of the 7SL-sRNA drops to undetectable levels. Therefore,
we believe that the 7SL-sRNA represents a suitably sensitive and specific marker for detection
of active infection in trypanosomes, with potential utility for both HAT and AAT.
Materials and methods
Ethics statement
Animal experiments were carried out at the Roslin Institute, University of Edinburgh under
the auspices of Home Office Project License number 60/4394. Studies were approved by the
Roslin Institute Animal Welfare and Ethical Review Board (study numbers L172 and L223).
Care and maintenance of animals complied with University regulations and the Animals
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(Scientific Procedures) Act (1986; revised 2013). Protocol plans for studies carried out at Clin-
vet were submitted to the Institutional Animal Care and Use Committee (IACUC), which
issued certificates of approval. The protocol was designed to allow the use of the study animals
in compliance with the Clinvet policy on the ethical use of animals, using the most recent ver-
sion South African National Standard (SANS) 10386 (The care and use of animals for scientific
purposes). Approved study numbers were CV 15/192 and CV 16/306.
In vivo infections
Samples from infected animals derive from two sources; (i) experimental infections carried
out at the Roslin Institute (T. brucei and T. congolense) and (ii) experimental infections carried
out as part of candidate drug testing by GALVmed/Clinvet (T. congolense and T. vivax).
i. Experimental infections of cattle (post-weaning male Holstein-Friesian cattle approximately
4–6 months of age; n = 4 per trypanosome species) were carried out in vector proof contain-
ment at the Roslin Institute. 1 x 106 trypanosomes (T. brucei AnTat 1.1 or T. congolense
IL3000) were inoculated intravenously via the jugular vein, and infections followed for 28
days. Parasitaemia was measured every two days in jugular blood samples by the quantita-
tive buffy coat technique [26]. Serum or plasma was also prepared at each sampling time-
point; for plasma, blood was centrifuged at 1500 x g for 15 minutes at room temperature
and supernatant (plasma) was removed.
ii. Samples were received (GALVmed/Clinvet) from in vivo studies in groups of cattle that
aimed to test clinical efficacy of a candidate trypanocidal drug. Experimental animals (Hol-
stein-Friesian, male and female, 2 months post-weaning and at least 4 months of age) were
infected by intravenous injection via the jugular vein, 21 cattle with T. vivax (STIB 719) and
21 cattle with T. congolense (KONT 2/133), with approximately 1 x 105 viable parasites in
fresh cow blood. Animals were divided into control (3 animals) and experimental groups
(18 animals; 3 groups of 6). Upon reaching first peak of parasitaemia, the control group was
treated with saline and the 3 sample groups of experimental animals were treated with dif-
ferent dosages of the candidate trypanocide drug, both administered intramuscularly. A
rescue treatment was administered for both control and experimental animals when parasi-
taemia persisted for 7 consecutive days, or clinical signs warranted intervention, in the
form of isometamidium chloride (1 mg/kg) or diminazene aceturate (7 mg/kg). Infection
levels were determined by microscopy every 2 to 3 days [27] and plasma samples were col-
lected for RNA extraction and 7SL-sRNA determination at approximately weekly intervals.
Plasma was prepared by centrifuging blood at 1800 x g for 10 minutes at room temperature
and removing supernatant (plasma).
In vitro culture
T. congolense IL3000 BSF parasites were cultured in TcBSF3 medium [28] supplemented with
20% adult goat serum (Gibco), 0.12 mM 2-mercaptoethanol and penicillin/streptomycin and
incubated at 34˚C, 5% CO2. Cells were routinely passaged and maintained at a density between
5 × 104 cells/mL and 3 × 106 cells/mL, unless stated otherwise.
T. brucei Lister 427 cells were cultured in HMI-11 [29] supplemented with 10% FBS, 0.2
mM 2-mercaptoethanol and penicillin/streptomycin, and maintained at 37˚C, 5% CO2. Cells
were maintained between 2 × 104 cells/mL and 2 × 106 cells/mL. Bloodstream forms of group
1 T. b. gambiense strain ELIANE were cultured in HMI-9 supplemented with 20% serum plus,
as previously described [30].
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RNA extraction
RNA extractions were conducted using the TRIzol LS reagent (Invitrogen) following the man-
ufacturer’s instructions. 250 μL of starting material in the form of serum/plasma for in vivo
experimental infections carried out at the Roslin Institute (T. brucei and T. congolense) was
used; where the sample was less than 250 μL, distilled water was added to make up the volume.
For in vivo samples received from GALVmed/Clinvet, RNA was extracted from 125 μL of
plasma with distilled water added to make up the volume to 250 μL. In cases where in vitro cul-
ture supernatants were used for RNA extraction, 500 μL supernatant was centrifuged at 2,000
× g for 10 minutes to remove cells from the medium. Subsequently, 250 μL supernatant was
used for downstream experiments.
RNA deep sequencing
Libraries were prepared using the TruSeq Small RNA library preparation kit (Illumina) with
10 μL total RNA as starting material (quantity of total RNA for each sample: uninfected
serum– 39ng, infected sample 1 – 230ng, infected sample 2 – 270ng, parasite cell pellet–
2.1μg). Samples were enriched using 15 cycles of PCR and library products of 145–160 bp were
gel purified, quantified and pooled for sequencing. The library pool was sequenced using a
HiSeq 2500 with 50-base single end reads and V4 chemistry.
RT-qPCR
A species-specific 7SL-derived small RNA stem loop primer-probe detection assay was opti-
mised, using custom primer and probe mixes made by Life Technologies, based on specific
sequences (Custom TaqMan Small RNA assay, cat. number: 4398989 [assay IDs T. brucei:
CTFVKNM; T. congolense: CTRWEM9; T. vivax: CTDJXGZ]). Reverse transcription was car-
ried out using a commercial cDNA Reverse Transcription Kit (Applied Biosciences, cat. num-
ber: 4368814), replacing the random primers with the aforementioned TaqMan assay primer.
Typically, 100 ng RNA was used per 15 μL reaction. The following thermocycling conditions
were applied for the RT reaction: 16˚C for 30 minutes, 42˚C for 30 minutes and 85˚C for 5
minutes to inactivate the reverse transcriptase.
In vivo RNA samples from the GALVmed/Clinvet trial were isolated from plasma derived
from heparinised blood and therefore required 2 units of Bacteroides Heparinase 1 (New
England BioLabs, cat. number: P0735) per RT reaction.
Subsequent to the RT reaction, a qPCR was performed using a commercial kit (TaqMan
universal PCR master mix, Thermo, cat. number: 4304437), according to manufacturer’s
instructions. At this stage, 1 μL custom prime-probe was also added to the qPCR reaction,
along with 1.5 μL RT reaction. The qPCR cycling profile was as follows: 50˚C for 2 minutes,
95˚C for 10 minutes and 40 cycles of 95˚C for 15 seconds and a probe detection step of 60˚C
for 1 minute.
When serum was used as a substrate for RT-qPCR, samples were heat treated at 65˚C for 15
minutes and 6 μL of the serum used per RT reaction. Single step RT-PCR reactions were per-
formed according to manufacturer’s guidelines (TaqMan RNA-to-Ct 1-Step Kit, Life Technol-
ogies, cat. number: 4392653). Single step RT-PCR reactions were performed using the
TaqMan small RNA assay primer and primer-probe mixes mentioned previously.
Bioinformatics
Raw RNA deep-sequencing data were subject to quality control using FastQC (v0.11.5) [31].
Adapter sequences were then removed from the reads, and data was filtered for read length
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between 20 and 39 base pairs using cutadapt v1.7.1 (parameters: “–a TGGAATTCTCGGG
TGCCAAGG–m 20 –M 39”) [32] Reads were subsequently aligned to the T. congolense IL3000
genome (TriTrypDB, v9.0), using Novoalign (v3.02.12, Novocraft Technologies), with the fol-
lowing parameters: “–l 20 –t 30 –h 60 –m–o SAM”. To quantify the alignments, the python
tool HTSeq-count was used with default parameters [33] with the T. congolense IL3000 tran-
script reference file in .gff format downloaded from TriTrypDB (v9.0) [21]. Data was normal-
ised by calculating reads per million (RPM): all read counts in a sample were first summed and
the sum divided by 1 million to generate a “per million” scaling factor. Read counts were sub-
sequently divided by this scaling factor to generate the RPM value for each gene. Raw and pro-
cessed data is available through GEO accession number GSE122858.
Results
Small RNA derived from the non-coding 7SL is detected at high levels in
the serum of infected cattle
Small RNAs in blood represent attractive diagnostic biomarkers as they tend to be relatively
stable, are easily accessible, and sensitive technologies exist for direct detection from serum
samples. To test whether trypanosomes secrete or excrete small RNAs during in vivo infec-
tions, total RNA was extracted using Trizol LS from serum samples obtained from two cattle
experimentally infected with the livestock trypanosome T. congolense (samples taken at day 19
post-infection, parasitaemia at time of isolation approximately 5 x 106 /mL), serum from an
uninfected control cow, and an in vitro-derived T. congolense cell pellet (approximately 4 x 107
cells). The RNA was submitted for small RNA deep sequencing, selecting for RNAs between
20- and 39-bp long. The resulting reads were aligned to the T. congolense genome (TriTrypDB
v9.0) using novoalign with strict parameters (one mismatch per read and a homopolymer filter
score of 60; normalised results and alignment statistics, are available in S1 Table and S2 Table).
A total of 15,645,557 and 16,770,619 reads were obtained for the two samples from infected
cattle after filtering for read length between 20-bp and 39-bp. Of these, 4.2% (654,025 reads)
and 1.3% (218,788 reads) were uniquely mapped to the T. congolense genome. 6,290,490 reads
were obtained from the uninfected cattle sample, with only 0.03% (1,804 reads) aligning
uniquely to the T. congolense genome. Reads were also aligned to a bovine genome (Bos taurus,
UMD [34] (S2 Table). These results indicated that 87.4%, 87.3% and 78.6% of reads from the
first infected, second infected and uninfected cattle samples, respectively, aligned to the bovine
genome (including both uniquely aligned and multimapped reads).
A total of 9,439,764 reads were generated from RNAseq of the T. congolense cell pellet sam-
ple, with 11.5% (1,084,005 reads) and 58.9% (5,557,663 reads) unique and multimapped reads
aligning to the T. congolense genome, respectively. The relatively high number of unmapped
reads (2,787,320; 29.5%) in this sample with respect to the T. congolense genome is explained
by the comparatively incomplete assembly and annotation of the reference T. congolense
genome when compared to, for example, the genome of T. brucei.
Subsequent analysis showed that the majority of mapped reads in the uninfected cattle sam-
ple that mapped to the T. congolense genome aligned to ribosomal RNA (rRNA) loci, the
sequences of which are known to be deeply conserved in eukaryotes [35]. For this reason,
rRNA alignments were omitted from downstream analyses as a data filtering step as they are
therefore unlikely to be useful molecular diagnostic targets. Read counts from annotated
regions of the T. congolense genome were generated using HTSeq-count, resulting in total read
counts mapping uniquely to annotated features of 42,302 and 18,230 for the two infected
samples, 322,385 for the pellet sample and 524 for the uninfected sample. Read counts were
normalised for library depth (reads per million; RPM). Strikingly, after eliminating reads
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associated with rRNA loci, the majority of reads from both infected serum samples originated
from one specific 26-bp sequence (Fig 1; normalised dataset in S1 Table). Indeed, there was a
substantial difference between the abundance of this small RNA and the next most abundant
Fig 1. RNA-sequencing of serum isolated from T. congolense-infected cattle reveals a parasite-specific 7SL-derived small RNA. A) Read
counts normalised by RPM of the ten most abundant small RNAs detected in T. congolense-infected serum (Gene IDs: 1 –TcIL3000_8_
ncRNA004; 2 –TcIL3000_10_12320; 3 –TcIL3000_0_34310; 4 –TcIL3000_0_tRNA019; 5 –TcIL3000_10_tRNA006; 6 –TcIL3000_10_12310; 7 –
TcIL3000_0_25440; 8 –TcIL3000_10_tRNA003; 9 –TcIL3000_10_tRNA002; 10 –TcIL3000_0_14280). B) Visualisation of the location of the
7SL-sRNA identified at high abundance in infected serum. The panels below show read alignments of the 26-bp sequence in two serum
samples from infected cattle, as well as read count from an in vitro-derived T. congolense cell pellet and an uninfected serum control, in the
form of histograms. Also visible is a smaller peak corresponding to a potential passenger strand. C) The mfold web server was used to generate
the predicted secondary structure of the T. congolense 7SL RNA. The 7SL-sRNA is highlighted in red.
https://doi.org/10.1371/journal.pntd.0007189.g001
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small RNA observed in infected serum, as well as uninfected and cell pellet controls (Fig 1A,
detailed in Table 1). The reduced levels of the small RNA in the cell pellet sample relative to
the serum samples and subsequent analysis of culture supernatant (see below & Fig 2), suggests
that the RNA species is rapidly secreted/excreted from the cell post-processing. Further analy-
ses indicated that the sRNA uniquely mapped to a single copy locus on chromosome 8 that
comprised part of the 275-bp 7SL RNA gene (Signal Recognition Particle (SRP) RNA, T. con-
golense Gene ID: TcIL3000_8_ncRNA004; T. brucei Gene ID: Tb927.8.2861) (Fig 1B), and is
henceforth referred to as “7SL-sRNA”. The full secondary structure of the 7SL RNA is shown
in Fig 1C, with 7SL-sRNA highlighted in red. Notably, a sequence corresponding to the 7SL-
sRNA complementary strand was also detected in the RNAseq data, although at approximately
ten-fold lower abundance, suggesting the existence of a passenger strand following processing
of the 7SL-sRNA (Fig 1B). There were no sequences corresponding to the host 7SL RNA
detected, suggesting that generation of a small RNA from the 7SL RNA is specific to trypano-
somes and not a general feature of 7SL RNA processing.
RT-qPCR assay targeting trypanosome 7SL small RNA is highly sensitive
and species-specific
The 7SL-sRNA sequence of T. congolense was aligned to the genome assemblies of several spe-
cies of African trypanosome to determine whether related trypanosome species encode for the
7SL-sRNA species. Sequences corresponding to the 7SL-sRNA were clearly identifiable in the
genomes of all related trypanosome species examined, suggesting expression of 7SL-sRNA
may be a common feature of African trypanosomes, and indeed, related trypanosomatids.
Whilst no sequence variation was observed across any of the T. brucei subspecies (specifically
T. b. brucei, T. b. gambiense, T. b. rhodesiense and T. b. evansi), there were several nucleotide
polymorphisms relative to the T. brucei sequence in both the T. vivax and T. congolense
sequences, raising the possibility that specific assays could be designed to distinguish between
the three primary livestock trypanosome pathogens (Fig 2A). To investigate this further, cus-
tom-designed primers were developed using existing stem-loop technology for each individual
species and RT-qPCR experiments performed (Fig 2B). Each primer set was applied to RNA
extracted from serum samples from cattle experimentally infected with each species to test for
cross-reactivity. Results show that sequence divergence of the 7SL-sRNA is sufficient to enable
the design of RT-qPCR assays that differentiate between T. vivax, T. congolense and T. brucei
with no detectable cross-reactivity (Fig 2C). Importantly, when applied to supernatants
derived from the human-infective T. b. gambiense (ELIANE strain) the T. brucei RT-qPCR
Table 1. Normalised read counts (RPM) of the 10 most abundant small RNAs detected in T. congolense-infected host serum (excluding rRNA).
Gene ID Infected
serum 1
Infected
serum 2
In vitro
cell pellet
Uninfected serum
TcIL3000_8_ncRNA004-1 793,414.02 734,064.73 11,114.04 13,358.78
TcIL3000_10_12320–2 37,752.35 66,867.80 64,959.60 9,541.98
TcIL3000_0_34310–1 26,901.80 38,069.12 30,655.89 3,816.79
TcIL3000_0_tRNA019-1 9,503.10 12,506.86 8,924.11 1,908.40
TcIL3000_10_tRNA006-1 9,384.90 15,304.44 3,694.34 0.00
TcIL3000_10_12310–1 9,290.34 18,211.74 47,238.55 11,450.38
TcIL3000_0_25440–1 6,311.76 8,776.74 40,656.36 11,450.38
TcIL3000_10_tRNA003-1 5,957.17 13,768.51 409.45 1,908.40
TcIL3000_10_tRNA002-1 3,616.85 12,177.73 7,683.36 0.00
TcIL3000_0_14280–1 2,836.75 3,455.84 9,665.46 1,908.40
https://doi.org/10.1371/journal.pntd.0007189.t001
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assay resulted in positive detection of the 7SL-sRNA, highlighting the potential of the sRNA
for diagnostics in human disease (Fig 2C).
Monitoring in vitro 7SL-sRNA excretion/secretion
For the 7SL-sRNA to be a suitable target for development of molecular diagnostics, there is a
requirement that the sRNA is constitutively released into the bloodstream, rather than only
under certain conditions such as cellular stress, as has recently been shown with, for example,
the spliced leader RNA [36]. To investigate this, time courses lasting 3 days (72 hours) were
Fig 2. 7SL-sRNA sequence enables differentiation between animal-infective trypanosome species. A) The 26-bp 7SL-sRNA sequence identified in T.
congolense serum was aligned to that from other trypanosomatids, revealing species-specific differences that were flanked by conserved guanosine
repeats. The polymorphisms were utilised to design species-specific Taqman RT-qPCR assays. B) Schematic representation of the Taqman RT-qPCR
assay, a 2 step based assay that makes use of step-loop primers as previously described in [56]. C) Assays generated for the detection of T. b. brucei, T.
vivax and T. congolense were applied to RNA samples extracted from plasma from infected animals, adjudged to exhibit similar parasitaemia scores. In
each case, only the species for which the assay was designed was detected by RT-qPCR and were statistically significant (alpha = 0.05) as determined by
Wilcoxon Signed Rank test, P value (two tailed)<0.0001 and n = 4. Red dotted line indicates limit of detection. The T. brucei assay was also tested on
RNA extracted from T. b. gambiense culture supernatants (n = 3, average cell density of 1.56 x 106 cells/mL).
https://doi.org/10.1371/journal.pntd.0007189.g002
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carried out using in vitro cultures of both T. brucei (Lister 427) and T. congolense (IL3000).
Cells were seeded at 5 × 104 cells/mL (n = 2), and density was periodically counted by haemo-
cytometer and supernatant samples were taken simultaneously for RT-qPCR analysis (Fig 3).
By the first time-point, the small RNA was readily detected in both T. brucei (Fig 3A) and T.
congolense (Fig 3B) supernatants (mean cell densities: T. brucei, 2.37 × 105 cells/mL; T. congo-
lense, 3.5 × 104 cells/mL), as calculated relative to the zero hour time point. Furthermore, rela-
tive 7SL-sRNA levels appeared to increase correlating with cell density (T. brucei: Pearson =
0.7724, Spearman ρ = 0.9643; T. congolense: Pearson = 0.9353, Spearman ρ = 0.9643; Fig 3A).
Fig 3. 7SL-sRNA abundance is correlated to cell density in cultured trypanosome supernatants. Cell density of in vitro cultures of T. brucei (A) and T.
congolense (B) was monitored over time and supernatant samples were simultaneously isolated for 7SL-sRNA detection (n = 2 per time point). (C) Relative
levels of the 7SL-sRNA, normalized to the 0 hour time-point control, were observed to increase as cell density increased; statistical significance of correlation
between cell density and relative Ct value was calculated by Spearman Rank correlation and Pearson’s product moment correlation.
https://doi.org/10.1371/journal.pntd.0007189.g003
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Taken together, these data indicate that the 7SL-sRNA is constitutively released by both species
of parasite, and indeed, relative abundance of the sRNA can give an indication of cell density
in parasite cultures. Interestingly, when 7SL-sRNA levels were corrected for cell number and
directly compared, levels of 7SL-sRNA accumulated more rapidly in T. congolense than T. bru-
cei cultures, suggesting there may be species-specific kinetics of extracellular production
(Fig 3C).
7SL-sRNA is detected before parasitaemia is detectable by microscopy and
during remission phase
To further investigate the suitability of the 7SL-sRNA as a diagnostic for monitoring disease
progression, serum samples were obtained from an in vivo study of six calves experimentally
infected with 1 × 106 T. brucei AnTat 1.1, which remained untreated for the duration of infec-
tion. The infection time courses ranged from six to 28 days depending on the severity of infec-
tion and day of euthanasia, and parasitaemia score was determined by microscopy
approximately every two days (Fig 4). Total RNA was extracted from serum samples and ana-
lysed by RT-qPCR. The relative expression of 7SL-sRNA was calculated relative to the zero
hour time point.
Parasites were typically detected in blood by microscopy after 4 days (Fig 4). In contrast,
the 7SL-sRNA was detected by day 2, suggesting higher sensitivity compared to microscopy.
Furthermore, following the first peak of parasitaemia, parasites became subpatent by micros-
copy, yet the 7SL-sRNA was still detectable at high levels during this time (animals 6630 and
6632; Fig 4).
Interestingly, data indicated that parasitaemia in animal 6630 remained undetectable by
microscopy after day 16 (Fig 4), when no further parasites were detected until infections were
terminated at day 28. However, 7SL-sRNA remained detectable, suggesting that this animal
was suffering from a chronic stage of disease. Therefore, microscopy resulted in a false negative
diagnosis but the RT-qPCR clearly remained sensitive, with a lower detection threshold than
microscopy. However, the result could also indicate that the RNA is stable in the bloodstream
and remains detectable after live parasites have been cleared. To investigate this further, we
next focused our attention on animals undergoing treatment.
Detection of 7SL small RNA accurately predicts active infection and
parasite clearance
Monitoring of disease progression is a vital aspect of treatment as well as for the development
of optimised chemotherapeutics, which require their efficacy to be accurately measured during
clinical trials. To this end, we used the 7SL-sRNA RT-qPCR assay on samples obtained from
clinical trials performed on cattle experimentally infected with T. congolense (Fig 5) or T. vivax
(Fig 6). The objectives of this study were primarily to test how the assay would compare with
other traditional measurements of disease progression such as microscopy, and to evaluate
whether the 7SL-sRNA remains present in the bloodstream when an infection is cleared by
chemotherapy. Importantly, trial animals were monitored for 85 days, allowing long-term fol-
low-up sampling and analysis, and assessment of the utility of the 7SL-sRNA as a marker of
active infection (e.g. in the event of treatment failure).
In all 21 cattle infected with T. congolense (KONT 2/133) (Fig 5; full data in S1 Fig), an ini-
tial wave of parasitaemia was observed by microscopy after ~5 days. Whilst no plasma samples
were available to test between day 0 and day 8, 7SL-sRNA was detected at the earliest post
infection time-point available in all cattle. In these analyses data was normalised to a sample
taken six to eight days preinfection. Upon experimental treatment of the cattle, there was a
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marked decrease in parasitaemia as determined by microscopy, which was mirrored by 7SL-
sRNA detection assays carried out at the nearest time-points post-treatment (Fig 5). This
observation was exemplified by animals 519 and 549, where plasma sampled just one day after
treatment was available for testing and there was no detectable 7SL-sRNA signal, as well as
there being no detectable trypanosomes by microscopy (Fig 5). Indeed, 7SL-sRNA was rarely
detected after treatment for the duration of the trial.
Fig 4. In vivo detection of T. brucei-specific 7SL-sRNA. Six calves (Holstein-Friesian male, approximately 4–6 months old) were
infected with T. brucei (AnTat 1.1) and monitored for up to 28 days. Parasitaemia (right axis) was determined every 2 days on average,
by microscopic detection of parasites; indicated by grey bars; approximate equivalent parasitaemia (parasites/mL): 1 = 1 x 102; 2 = 1 x
103; 3 = 1 x 104; 4 = 1–5 x 105; 5 = 5 x 105–5 x 106; 6 =>5 x 106; grey bars measuring zero (red line) indicate where parasitaemia was
measured but not detected, and no bar indicates that parasitaemia was not measured. Relative expression of 7SL-sRNA as measured by
RT-qPCR (left axis) is shown by the black line graph, and was calculated by normalising to an uninfected serum control. Asterisk
indicates euthanasia of an animal.
https://doi.org/10.1371/journal.pntd.0007189.g004
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Fig 5. In vivo detection of T. congolense-specific 7SL-sRNA. Twenty-one cattle were challenged with T. congolense (KONT2/133), and subsequently
divided into four groups depending on a treatment regimen with a candidate trypanocide. Of the 21, data from eight cattle are shown. Parasitaemia scores
(right axis) were measured by microscopy every two to three days, indicated by grey bars; approximate equivalent parasitaemia (parasites/mL): 1 = 1 x 102;
2 = 1 x 103; 3 = 1 x 104; 4 = 1–5 x 105; 5 = 5 x 105–5 x 106; 6 =>5 x 106; grey bars measuring zero (red line) indicate where parasitaemia was measured but
not detected, and no bar indicates that parasitaemia was not measured. Plasma samples were obtained at longer intervals (approximately weekly) from
A trypanosome small RNA is a marker of active infection
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Interestingly, in one case (animal 549), 7SL-sRNA was detected after 42 days, suggesting a
relapse. Almost 15 days later, live trypanosomes were observed by microscopy, after which the
infection was once again cleared (Fig 5). A similar phenomenon was observed in animals 526
and 528, where no parasitaemia was detected by microscopy, again suggesting relapse of infec-
tion, detectable by RT-qPCR but not by microscopy.
Importantly, these results indicate that 7SL-sRNA is short-lived in vivo, as successful drug
treatment rapidly leads to the loss of signal, suggesting active infections are required to sustain
the high abundance of the 7SL-sRNA. This further highlights the potential of 7SL-sRNA as a
diagnostic for active trypanosome infections, rather than simply exposure such as is observed
using antibody-based serological tests.
Samples from a second clinical trial involving 21 cattle experimentally infected with T.
vivax (STIB 719) were also tested using the T. vivax-specific RT-qPCR assay (Fig 6; full data in
S2 Fig). As with the T. congolense study, parasitaemia was measured every 2–3 days, and
plasma samples were obtained more sporadically (approximately weekly) over a period of 85
days post-infection. Treatment was administered after peak parasitaemia was observed by
microscopy, typically after ~14 days. For the T. vivax trials, rescue treatment was administered
if the trial compound failed.
As demonstrated for T. congolense, 7SL-sRNA was detected by the first available time point,
and once again mirrored parasitaemia observed by microscopy. In most cattle, T. vivax was
cleared post-treatment (exemplified by animals 496, 511, 515, 520, 522, 532, 544, and 538), and
the 7SL-sRNA signal was absent at the next sampling timepoint (typically 7–10 days later).
However, in several cases, the presence of 7SL-sRNA was detected in time points where no
parasites were observed by microscopy, again highlighting the increased sensitivity exhibited
by the RT-qPCR compared to microscopy. Indeed, in these cases, such as animals 498, 524 and
527, 7SL-sRNA appeared to indicate cyclical changes in parasitaemia commonly associated
with trypanosome infections (Fig 6).
The above theory was further strengthened when investigating several animals that suffered
from relapse of infection due to treatment failure, as confirmed by microscopy (in particular,
animals 502, 543 and 550) (Fig 6). In animal 543, 7SL-sRNA plasma levels increased after day
30, without a corresponding increase in parasitaemia. Parasites were finally observed by
microscopy on day 55, more than 3 weeks after detection of relapse by 7SL-sRNA.
Therefore, by RT-qPCR analysis of a highly abundant secretory/excretory small RNA,
infection status was confirmed more accurately than by microscopy. Further analysis is
required, ideally with time courses that include frequent sampling of host serum pre- and
post-treatment, including at subtherapeutic doses, in order to accurately determine both the
kinetics of decay of 7SL-RNA signal after successful treatment and the association between
treatment failure, parasite dynamics and 7SL-RNA signal.
7SL-sRNA is detected directly from serum with one-step RT-qPCR assay
Whilst our data suggests that the 7SL-sRNA presents a realistic target for development of a
molecular diagnostic for both HAT and AAT, in reality for diagnostic assays to be field-appli-
cable in the settings in which both diseases occur, an assay requires several attributes: high on
this list are two related aspects—low cost and minimal number of processing steps. A two-step
RT-qPCR involving a lengthy RNA extraction protocol is therefore not desirable. We therefore
which RNA was extracted; 7SL-RNA RT-qPCR results (left axis) are shown by the black line graph, and and were calculated by normalising to an
uninfected serum control; green diamond indicates day when animal was treated with a rescue drug (isometamidium chloride or diminazene aceturate)
and red diamond indicates when test drug was administered.
https://doi.org/10.1371/journal.pntd.0007189.g005
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Fig 6. In vivo detection of T. vivax-specific 7SL-sRNA. Twenty-one cattle were challenged with T. vivax (STIB 719), and subsequently divided into four
groups depending on a treatment regimen with a candidate trypanocide. Of the 21, data from eight cattle are shown. Parasitaemia scores (right axis) were
measured by microscopy every two to three days, indicated by grey bars; approximate equivalent parasitaemia (parasites/mL): 1 = 1 x 102; 2 = 1 x 103; 3 = 1
x 104; 4 = 1–5 x 105; 5 = 5 x 105–5 x 106; 6 =>5 x 106; grey bars measuring zero (red line) indicate where parasitaemia was measured but not detected, and
no bar indicates that parasitaemia was not measured. Plasma samples were obtained at longer intervals (approximately weekly) from which RNA was
A trypanosome small RNA is a marker of active infection
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007189 February 19, 2019 15 / 23
investigated whether a one-step RT-qPCR would simplify the assay and if the RNA could be
detected directly from serum samples without the requirement for RNA extraction (Fig 7).
Using RNA samples from T. brucei infected animal 6632 (Fig 4), we demonstrated that the
one-step RT-qPCR detected 7SL-sRNA at every timepoint where the small RNA was detected
by the two-step assay (Fig 7A). Additionally, serum or plasma samples from both T. congolense
and T. brucei-infected cattle were assayed using one-step RT-qPCR reactions, which were per-
formed on 6 μL serum/plasma in a 15 μL reaction. For both T. brucei and T. congolense (Fig
7B), 7SL-sRNA was readily detected. Finally, serum samples from a T. brucei in vivo infection
time-course that included periods of patent and subpatent parasitaemia by microscopy (ani-
mal 6630) were re-tested using the single step assay (Fig 7C). Again the assay was able to clearly
detect 7SL-sRNA, albeit with reduced sensitivity, during active infection even when infection
was in remission and no parasitaemia could be detected by microscopy.
These results demonstrate that assays for 7SL-sRNA are species-specific, highly sensitive,
and can be detected the RNA before the onset of parasitaemia as well as during periods where
there is subpatent parasitaemia by microscopy. Moreover, the 7SL-sRNA can also be detected
directly from serum using a one-step RT-qPCR assay.
Discussion
To meet the challenges of both elimination of HAT and management of AAT, improved diag-
nostic techniques are crucial. Current methods of diagnosis are suboptimal, particularly for
AAT, and this is hindering progress on reducing the disease burden [3, 4]. Traditionally diag-
nosis for both HAT and AAT relies upon microscopy—this depends on a minimum threshold
of parasitaemia in order to accurately detect infection (even with parasite concentration meth-
ods), and as our data illustrates there are often long periods of subpatent parasitaemia in try-
panosome infections that is then problematic for microscopy diagnosis. In addition, the
traditional reliance upon the presence of parasites in venous blood does not take into account
recent reports of extravascular reservoirs of the parasite, such as the skin [37, 38] and adipose
tissue [39] (which also seems to correlate with periods of subpatency in peripheral blood). Sev-
eral potentially useful diagnostic approaches are sensitive and specific (e.g. traditional PCR),
but are expensive and not easily field-applicable, and DNA-based tests can face the issues of
DNA still circulating post-treatment and the potential for easy cross-contamination. Finally,
some antibody-based diagnostic tests are available, and are effective and field applicable, such
as the CATT test for HAT and VerY Diag for AAT, but antibody tests have a challenge in dif-
ferentiating between active infection and exposure (additionally the CATT test only detects T.
b. gambiense—there is currently no field-applicable test available for T. b. rhodesiense). There-
fore, sensitive and specific markers of active infection are still required for both HAT and
AAT.
In this study we identified a species-specific small RNA excreted/secreted by all three AAT
relevant species, as well as the main causative agent of HAT, T. b. gambiense, at physiologically
relevant abundances both in vivo and in vitro. Crucially, the RNA, termed 7SL-sRNA, is indic-
ative of active infection and is detected even when parasitaemia is below levels detectable by
microscopy. Furthermore, successful drug treatment results in rapid loss of detectable 7SL-
sRNA signal, thereby exhibiting a key characteristic of a marker that correlates with active
infection.
extracted; 7SL-RNA RT-qPCR results (left axis) are shown by the black line graph, and and were calculated by normalising to an uninfected serum control;
green diamond indicates day when animal was treated with a rescue drug (isometamidium chloride or diminazene aceturate) and red diamond indicates
when test drug was administered.
https://doi.org/10.1371/journal.pntd.0007189.g006
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Fig 7. 7SL-sRNA can be detected by directly from serum using a one-step RT-qPCR. A) Serum samples from a T. brucei infected cow (animal 6632, Fig 4)
were directly applied to a one-step RT-qPCR reaction, and the results compared to the two-step RT-qPCR reaction and parasitaemia scoring by microscopy.
In all cases the sRNA was detectable although expression levels were slightly decreased. Parasitaemia scores (right axis) are indicated by grey bars; grey bars
measuring zero (red dashed line) indicate where parasitaemia was measured but not detected, and no bar indicates that parasitaemia was not measured. RT-
qPCR results (left axis) are shown by the black line (two step RT-qPCR) and red line (one step RT-qPCR) graph, and and was calculated by normalising to an
uninfected serum control. B) The use of serum as a direct substrate for the RT-qPCR was tested using 6 μL of serum, heat-treated at 65˚C for 15mins, from
both T. brucei and T. congolense infected animals, showing that the sRNA was detectable using this substrate (n = 2 per sample). C) The optimised one-step
RT-qPCR assay was applied to serum samples from a T. brucei-infected cow (animal 6630, Fig 4) in order to assess performance when parasitaemia is
undetectable for a substantial period. Similar to the two-step RT-qPCR carried out on RNA extracts, the 7SL-sRNA was still detectable when parasites were
not detectable by microscopy for 10 days, as judged by microscopy. Parasitaemia scores (right axis) are indicated by grey bars; grey bars measuring zero (red
dashed line) indicate where parasitaemia was measured but not detected, and no bar indicates that parasitaemia was not measured. RT-qPCR results (left axis)
are shown by the black line (two step RT-qPCR) and red line (one step RT-qPCR) graph, and and was calculated by normalising to an uninfected serum
control.
https://doi.org/10.1371/journal.pntd.0007189.g007
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Whilst this study was able to utilise samples from multiple experimental animal trials,
human blood or CSF samples that would be suitable for testing could not be identified,
although we hypothesise the 7SL-sRNA would also be present at similar levels in these types of
clinical samples in human patients–we tested culture supernatant from T. b. gambiense
(ELIANE) grown in vitro, and the level of signal was the same as observed with T. b. brucei.
Developing a diagnostic for HAT that is able to detect both T. b. gambiense and T. b. rhode-
siense would be greatly beneficial, as currently there is no molecular test that is widely used in
the field for T. b. rhodesiense diagnosis [3].
Whilst the 7SL-sRNA is detectable using laboratory PCR machines, these assays are clearly
not field applicable in their current state, and further work must be carried out to adapt the
assays (e.g. to the loop mediated isothermal amplification (LAMP) platform; see below) to be
field applicable. However, there have also been considerable efforts to exploit differential host
small RNA levels as biomarkers of disease states in human medicine, in particular miRNAs in
cancer, which has led to several other potentially field-applicable diagnostic techniques that
could be adapted to detect 7SL-sRNA.
Several other technologies have the potential to be alternative platforms suitable for small
RNA detection. In particular, the LAMP assay, which has been previously developed for all three
livestock trypanosome species based on gDNA targets [13, 40, 41] and for which a test intended
for field application was developed for HAT [14], has been shown to be suitable for application to
small RNA as an assay substrate [42, 43] and therefore could potentially be optimised to develop a
field-applicable 7SL-sRNA assay. Another recently developed method, Recombinase Polymerase
Amplification (e.g. [44]), exhibits potential as an extremely sensitive detection method, even sur-
passing the aforementioned LAMP assay. This process requires a reaction consisting of a recombi-
nase, a single-stranded DNA-binding protein and a strand-displacing polymerase to amplify the
target [45]. Importantly, this method can be carried out at low temperatures, and amplification
has been shown to proceed using just body heat [46]. By coupling this assay to a lateral flow device
or a dipstick using biotinylated primers, the target can be visualised by eye, thereby bypassing the
need for thermocycler or real-time fluorescence detection. Whilst RPA typically requires targets
consisting of>30 bp, this technology has recently been adapted to the detection of miRNAs by
ligating highly specific probes to the miRNA using a PBCV-1 ligase [47].
The discovery of a small RNA secreted/excreted by African trypanosomes at high abun-
dance also raises interesting and potentially important biological questions. There is currently
a great deal of interest in the ability of pathogens to communicate with each other and to
manipulate host functions through the delivery of small RNAs [48]. Communication between
trypanosomes during infection is required to regulate differentiation in a population density-
dependant manner [49]. Trypanosome infection also has substantial effects on host cells, for
example the ablation of B cells and consequent loss of immune memory through an as yet
undefined ligand [50]. A small RNA, such as 7SL-sRNA could directly regulate gene expres-
sion, as is the case with miRNAs, or act as a signalling molecule, potentially triggering or inhib-
iting immunoregulatory pathways in host cells. Studies have demonstrated that small RNAs
are often packaged, secreted and delivered to target cells via extracellular vesicles such as exo-
somes. The 7SL RNA has been detected in exosomes from other trypanosomatids including
Leishmania spp. [51] and Trypanosoma cruzi, a closely related pathogen that causes Chagas’
disease in South America [52]. However, in these datasets, the significance of this finding and,
indeed, whether the entire 7SL RNA or just a portion of it were observed, were not discussed.
Studies are currently underway to determine whether 7SL-sRNA is released from the parasite
in a vesicle or exists freely. Furthermore, it is yet to be determined whether 7SL-sRNA exists as
part of a larger complex. Its stability in serum would suggest the RNA is somehow protected
from RNase activity.
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In addition to the potential biological role of 7SL-sRNA, how the small RNA is processed
and released from trypanosomes is yet to be determined. The existence of a potential passenger
strand could suggest a role for DICER in processing the larger 7SL RNA, as this type III endo-
nuclease has previously been shown to process mammalian 7SL RNA [53]. Intriguingly, previ-
ous studies have noted the absence of a conserved eukaryotic SRP complex protein in a related
trypanosomatid species. Instead, isolation of the 7SL RNA revealed a co-migratory tRNA-like
molecule (sRNA-85 in Leptomonas collosoma [54], sRNA-76 in T. brucei [55]). The tRNA-like
molecule has extensive and precise complementarity to the region of 7SL RNA that is pro-
cessed to generate the small RNA. Finally, while our data is consistent with the 7SL-sRNA
being actively processed and secreted/excreted, we cannot currently formally rule out that par-
asite cell death or membrane damage may be contributing to the 7SL-sRNA signal.
In summary, we have detected a trypanosome small RNA (7SL-sRNA), derived from the
non-coding 7SL RNA of the SRP, which is excreted/secreted at high levels by T. brucei, T. con-
golense and T. vivax during infections. Species-specific RT-qPCR assays were developed, and
we have shown that there is good correlation between 7SL-sRNA levels and parasite numbers,
but importantly 7SL-sRNA can be detected both before patent parasitaemia and during phases
of infection when parasitaemia becomes subpatent (both chronic infection and treatment fail-
ure), and critically the 7SL-sRNA signal decays rapidly after successful chemotherapy. There-
fore, 7SL-sRNA represents a marker of active infection, and is a novel and viable target for the
development of much needed diagnostics for both HAT and AAT, and may also provide
insights into important host-pathogen interactions.
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S1 Fig. In vivo detection of T. congolense 7SL-sRNA. Twenty-one cattle were challenged with
T. congolense KONT2/133, and subsequently divided into four groups depending on a treat-
ment regimen with a candidate trypanocide. Data for the remaining 13 cattle are shown. Para-
sitaemia scores (right axis) were measured by microscopy every two to three days, indicated by
grey bars; approximate equivalent parasitaemia (parasites/mL): 1 = 1 x 102; 2 = 1 x 103; 3 = 1 x
104; 4 = 1–5 x 105; 5 = 5 x 105–5 x 106; 6 =>5 x 106; grey bars measuring zero (red line) indi-
cate where parasitaemia was measured but not detected, and no bar indicates that parasitaemia
was not measured. Plasma samples were obtained at longer intervals (approximately weekly)
from which RNA was extracted; 7SL-RNA RT-qPCR results (left axis) are shown by the black
line graph, and and were calculated by normalising to an uninfected serum control; green dia-
mond indicates day when animal was treated with a rescue drug (isometamidium chloride or
diminazene aceturate) and red diamond indicates when test drug was administered.
(PDF)
S2 Fig. In vivo detection of T. vivax 7SL-sRNA. Twenty-one cattle were challenged with T.
vivax, and subsequently divided into four groups depending on a treatment regimen with a
candidate trypanocide. Data for the remaining 13 cattle are shown. Parasitaemia scores (right
axis) were measured by microscopy every two to three days, indicated by grey bars; approxi-
mate equivalent parasitaemia (parasites/mL): 1 = 1 x 102; 2 = 1 x 103; 3 = 1 x 104; 4 = 1–5 x 105;
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5 = 5 x 105–5 x 106; 6 =>5 x 106; grey bars measuring zero (red line) indicate where parasitae-
mia was measured but not detected, and no bar indicates that parasitaemia was not measured.
Plasma samples were obtained at longer intervals (approximately weekly) from which RNA
was extracted; 7SL-RNA RT-qPCR results (left axis) are shown by the black line graph, and
and were calculated by normalising to an uninfected serum control; green diamond indicates
day when animal was treated with a rescue drug (isometamidium chloride or diminazene
aceturate) and red diamond indicates when test drug was administered.
(PDF)
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